-+ 0.00%
-+ 0.00%
-+ 0.00%

Rockwell Medical Sees FY2026 Sales $65.000M-$70.000M vs $75.153M Est

Benzinga·03/26/2026 10:08:02
Listen to the news

GUIDANCE

For the third year in a row, Rockwell Medical's annual performance was directly in line with its annual guidance. In 2025, Rockwell Medical's achieved net sales, gross margin and Adjusted EBITDA as follows:

  2025 Annual Guidance 2025 Actual
Net Sales $65.0M to $70.0M $69.3M
Gross Margin 16% to 18% 17%
Adjusted EBITDA ($0.5)M to $0.5M $0.4M

In 2026, we are working to drive sustainable, profitable growth by adding new customers and renewing contracts with existing customers, improving price and product mix, further enhancing operational efficiencies, and selectively expanding our portfolio through disciplined partnership and business development.

The Company projects its 2026 annual guidance as follows:

  2026 Annual Guidance
Adjusted EBITDA $1 million to $2 million
Operating Cash Flow Positive